Quick Answer
Elanco Animal Health Inc reported R&D Expense of $368.00 million for fiscal year 2025.
Elanco Animal Health Inc R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $368.00M | +7.0% |
| 2024 | $344.00M | +5.2% |
| 2023 | $327.00M | +1.9% |
| 2022 | $321.00M | -13.0% |
| 2021 | $369.00M | +12.2% |
| 2020 | $329.00M | +21.9% |
| 2019 | $270.00M | +9.5% |
| 2018 | $246.60M | -2.0% |
| 2017 | $251.70M | -5.3% |
| 2016 | $265.80M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $89.00M | +2.3% | -3.3% |
| June 30, 2025 | $92.00M | +3.4% | -2.1% |
| March 31, 2025 | $94.00M | +8.0% | +8.0% |
| September 30, 2024 | $87.00M | +1.2% | -2.2% |
| June 30, 2024 | $89.00M | +9.9% | +2.3% |
| March 31, 2024 | $87.00M | +7.4% | +1.2% |
| September 30, 2023 | $86.00M | +10.3% | +6.2% |
| June 30, 2023 | $81.00M | -1.2% | +0.0% |
- Elanco Animal Health Inc showed an increase of +7.0% in R&D Expense compared to the prior fiscal year.
- Over the 2016–2025 period, Elanco Animal Health Inc’s r&d expense has grown by 38.4% (from $265.80 million to $368.00 million).
- The most recent figure is from Elanco Animal Health Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: